Notice of Results

RNS Number : 6258X

Hutchison China Meditech Limited

20 February 2012

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Notice of Announcement of 2011 Final Results

London: Monday, 20 February 2012: Chi-Med will be announcing its final results for the year ended 31 December 2011 on Tuesday, 20 March 2012.  An analyst presentation will be held at 9:00am on the same day at Citigate Dewe Rogerson, 3 London Wall Buildings, London, EC2M 5SY.

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:      [phone]
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:      [phone] Mobile:             [phone] Mobile:             [phone]
Lazard & Co., Limited Paul Gismondi Nick Fowler	Telephone:      [phone]

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

NORMMGMZLNDGZZG